Abstract:Background SAG (Sensitive to Apoptosis Gene), also known as RBX2, ROC2 or RNF7, is a RING component of CRL (Cullin-RING ligase), required for its activity. Our recent study showed that SAG/RBX2 co-operated with Kras to promote lung tumorigenesis, but antagonized Kras to inhibit skin tumorigenesis, suggesting a tissue/context dependent function of Sag. However, it is totally unknown whether and how Sag would play in prostate tumorigenesis, triggered by Pten loss. Methods Sag and Pten double conditional knockout mice were generated and prostate specific deletion of Sag and Pten was achieved by PB4-Cre, and their effect on prostate tumorigenesis was evaluated by H&E staining. The methods of immunohistochemistry (IHC) staining and Western blotting were utilized to examine expression of various proteins in prostate cancer tissues or cell lines. The effect of SAG knockdown in proliferation, survival and migration was evaluated in two prostate cancer cell lines. The poly-ubiquitylation of PHLPP1 and DEPTOR was evaluated by both in vivo and in vitro ubiquitylation assays. Results SAG is overexpressed progressively from early-to-late stage of human prostate cancer with the highest expression seen in metastatic lesion. Sag deletion inhibits prostate tumorigenesis triggered by Pten loss in a mouse model as a result of suppressed proliferation. SAG knockdown in human prostate cancer cells inhibits a) proliferation in monolayer and soft agar, b) clonogenic survival, and c) migration. SAG is an E3 ligase that promotes ubiquitylation and degradation of PHLPP1 and DEPTOR, leading to activation of the PI3K/AKT/mTOR axis, whereas SAG knockdown caused their accumulation. Importantly, growth suppression triggered by SAG knockdown was partially rescued by simultaneous knockdown of PHLPP1 or DEPTOR, suggesting their causal role. Accumulation of Phlpp1 and Deptor with corresponding inactivation of Akt/mTOR was also detected in Sag-null prostate cancer tissues. Conclusions Sag is an oncogenic cooperator of Pten -loss for prostate tumorigenesis. Targeting SAG E3 ligase may, therefore, have therapeutic value for the treatment of prostate cancer associated with Pten loss.

Endothelial Deletion of Sag/Rbx2/Roc2 E3 Ubiquitin Ligase Causes Embryonic Lethality and Blocks Tumor Angiogenesis

SAG/RBX2/ROC2 E3 Ubiquitin Ligase is Essential for Vascular and Neural Development by Targeting NF1 for Degradation

Endothelial CDS2 deficiency causes VEGFA-mediated vascular regression and tumor inhibition

Inactivation of Sag/Rbx2/Roc2 E3 Ubiquitin Ligase Triggers Senescence and Inhibits Kras-Induced Immortalization

Sag/Rbx2 Partial Inactivation Sensitizes Mice to Radiation and Radiation-Induced Tumorigenesis1.

Inactivation of SAG E3 Ubiquitin Ligase Blocks Embryonic Stem Cell Differentiation and Sensitizes Leukemia Cells to Retinoid Acid

SUMOylated NICD in Endothelial Cell Suppresses Tumor Angiogenesis

Inactivation of Sag/Rbx2/Roc2 e3 ubiquitin ligase triggers senescence and inhibits kras-induced immortalization.

Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase

Disruption of Sag/Rbx2/Roc2 Induces Radiosensitization by Increasing ROS Levels and Blocking NF-κB Activation in Mouse Embryonic Stem Cells

Depletion of SAG/RBX2 E3 Ubiquitin Ligase Suppresses Prostate Tumorigenesis Via Inactivation of the PI3K/AKT/mTOR Axis

Inactivation of SAG/RBX2 E3 Ubiquitin Ligase Suppresses KrasG12D-driven Lung Tumorigenesis.

Validation of SAG/RBX2/ROC2 E3 Ubiquitin Ligase As an Anticancer and Radiosensitizing Target.

Sag/Rbx2 is A Novel Substrate of Nedd4-1 E3 Ubiquitin Ligase and Mediates Nedd4-1 Induced Chemosensitization

Transgenic Expression of Sag/Rbx2 E3 Causes Early Stage Tumor Promotion, Late Stage Cytogenesis and Acinar Loss in the Kras–PDAC Model

SAG/ROC/Rbx/Hrt, a Zinc RING Finger Gene Family: Molecular Cloning, Biochemical Properties, and Biological Functions

SAG/ROC2/RBX2 E3 ligase promotes UVB-induced skin hyperplasia, but not skin tumors, by simultaneously targeting c-Jun/AP-1 and p27.

SAG/ROC2/RBX2 is a HIF-1 target gene that promotes HIF-1α ubiquitination and degradation

SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IkappaB-alpha/NF-kappaB.

Sag/Roc2/Rbx2 is A Hif-1 Target Gene That Promotes Hif-1 Alpha Ubiquitination and Degradation

SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IκB-α/NF-κB